Androscoggin Home Care & Hospice uses Honeywell’s Genesis remote patient monitoring devices to communicate with and engage moderate to high-risk patients following a post-acute event. Since first implementing their telehealth program in 2001, the combination of monitoring devices and Honeywell’s clinical software – LifeStream Management Suite – has allowed them to consolidate and easily track patient data, helping them to achieve significant reductions in hospital readmissions. But a recent trend in patient telecommunications created the need for a wireless device solution, for which they’ve successfully utilized Honeywell’s new Genesis Touch.
When care providers at Androscoggin Home Care & Hospice, the largest Home Care & Hospice agency in Maine, initially launched their telehealth program, they were quickly able to see positive results from utilizing Honeywell’s Genesis family of remote patient monitoring devices to track the daily vital signs of patients and streamline patient-acquired data into one internet-accessible clinical dashboard.
In fact, initial success stories from the agency’s first 25 monitoring devices were so impactful, Androscoggin Home Care & Hospice decided to invest in acquiring more devices, and has since augmented their number of monitoring devices by more than 50 per year. They are now able to monitor more than 200 patients at one time, and have dramatically decreased overall hospital readmissions among their monitored patients – to as little as 6 percent in some cases (well below the national average of around 20 percent).
But recently, the agency noted that a telecommunications trend in their area was creating some additional challenges to providing remote patient monitoring services – the shift from almost all patients having land- line phone services to a number of patients moving to solely cellular usage – which made traditional land-line based telehealth devices unusable without the purchase of additional equipment.
Download this case study below to discover the solution and benefits.